Sumitomo Pharma Co., Ltd.
Climate Impact & Sustainability Data (2023)
Reporting Period: 2023
Environmental Metrics
ESG Focus Areas
- Product Development and Launch
- Quality and Safety
- Access to Medicines
- Employee Engagement
- Diversity and Inclusion
- Environmental Sustainability
- Corporate Governance
- Risk Management
- Compliance
Environmental Achievements
- Reduced GHG emissions (Scope 1+2) by 26% from fiscal 2020
- Maintained recycling rate at 83%
- Maintained final disposal rate below 1% at 0.1%
Social Achievements
- Held 11 lectures in the area of psychiatric disorders, 14 lectures related to Parkinson’s disease and dementia with lewy bodies, and 4 lectures in the area of diabetes.
- Conducted career interviews for approximately 200 employees.
- Implemented initiatives to improve employee engagement scores, although scores decreased compared to the previous year.
- Conducted human rights education and training for all employees.
Governance Achievements
- Maintained a good level of quantitative evaluation results in the effectiveness evaluation for the Board of Directors.
- Completed the reorganization of Group Companies in North America.
- Held four meetings of the Supervisory Committee for Conflict of Interests in Transactions between Group Companies.
- Zero serious compliance violations.
Climate Goals & Targets
Long-term Goals:
- Reduce GHG emissions (Scope 1+2) to zero by fiscal 2050
Medium-term Goals:
- Achieve 85% recycling rate by fiscal 2030
- Reduce water withdrawal by 12% vs. fiscal 2018 by fiscal 2030
- Lower final disposal rate to below 0.5% by fiscal 2030
- Have 100 citizen data scientists by fiscal 2024 and 150 citizen developers by fiscal 2027
Short-term Goals:
- Reduce GHG emissions (Scope 1+2) by 42% vs. fiscal 2020 by fiscal 2030
- Increase percentage of female managers to 20% or more by fiscal 2027
- Increase understanding of the whistle-blowing system to the same level as awareness by fiscal 2027
Environmental Challenges
- Lower than expected employee engagement scores.
- Decrease in the number of female managers.
- Increased water consumption due to increased production volume.
- Partial shipments of TWYMEEG® due to higher sales than demand forecast.
Mitigation Strategies
- Implemented initiatives tailored to each organization to address employee engagement challenges.
- Increased focus on training candidates for the next generation of female managers.
- Implemented initiatives to reduce water consumption.
- Implemented a 24-hour production system at the Suzuka Plant and strengthened active pharmaceutical ingredient production facilities to resume regular shipments of TWYMEEG®.